Mutations of isocitrate hydrogenase 1 and 2 (IDH1 and IDH2) genes are found in roughly 8% and 12% of AML cases, respectively, making up one of the most common genetic mutations following FLT3 [15,16]. Here, IDH2 is linked to acute myeloid leukemia.